Literature DB >> 31158368

Novel aspects of the role of the liver in carbohydrate metabolism.

Richard N Bergman1, Francesca Piccinini2, Morvarid Kabir2, Marilyn Ader2.   

Abstract

Malfunction of the liver is a central factor in metabolic disease. Glucose production by liver is complex and controlled via indirect mechanisms; insulin regulates adipose tissue lipolysis, and free fatty acids in turn regulate liver glucose output. This latter concept is confirmed by studies in L-Akt-Foxo1 knockout mice. The adipocyte is a likely locus of hepatic insulin resistance. Also, kidneys play a role in regulating glucose production; denervated kidneys abrogate the effect of fat feeding to cause insulin resistance. Glucose itself is an important regulator of liver metabolism ("glucose effectiveness"); after entering liver, glucose is phosphorylated and can be exported as lactate. Using the dynamic glucose/lactate relationship, we have been able to estimate glucose effectiveness in intact animals and human subjects. Families have been identified with a glucokinase regulatory protein defect; modeling demonstrates elevated glucokinase activity. Insulin clearance by liver is highly variable among normal individuals, and is under environmental control: high fat diet reduces clearance by 30%. Liver insulin clearance is significantly lower in African American (AA) adults and children compared to European American participants, accounting for fasting hyperinsulinemia in AA. We hypothesize that reduced hepatic insulin clearance causes peripheral insulin resistance and increased Type 2 diabetes in AA.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31158368     DOI: 10.1016/j.metabol.2019.05.011

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  4 in total

Review 1.  The Measurement of Insulin Clearance.

Authors:  Francesca Piccinini; Richard N Bergman
Journal:  Diabetes Care       Date:  2020-09       Impact factor: 19.112

Review 2.  Hepatic metabolic regulation by nuclear factor E4BP4.

Authors:  Zifeng Zhao; Lei Yin; Feihua Wu; Xin Tong
Journal:  J Mol Endocrinol       Date:  2021-01       Impact factor: 5.098

Review 3.  Hyperinsulinemia in Obesity, Inflammation, and Cancer.

Authors:  Anni M Y Zhang; Elizabeth A Wellberg; Janel L Kopp; James D Johnson
Journal:  Diabetes Metab J       Date:  2021-03-29       Impact factor: 5.893

4.  The Link between Obesity and Inflammatory Markers in the Development of Type 2 Diabetes in Men of Black African and White European Ethnicity.

Authors:  Olah Hakim; Oluwatoyosi Bello; Meera Ladwa; Janet L Peacock; A Margot Umpleby; Geoffrey Charles-Edwards; Stephanie A Amiel; Louise M Goff
Journal:  Nutrients       Date:  2020-12-11       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.